Lexaria Discusses Valuation Metrics for Biotech Industry
August 11, 2022
Consumer
-
-
Nextech AR Announces Multiple New 3D Modeling Contracts
August 11, 2022
-
Better Choice Company Reports Record Second Quarter 2022 Gross Sales and Provides Corporate Update
August 11, 2022
-
Muscle Maker, Inc. Posts Q2 2022 Results – Operating Profit Continues Improvement
August 11, 2022
-
LiveOne Reports Q1 Fiscal 2023 Revenue of $23.2 Million and Maintains Guidance for Fiscal 2023 of Revenue Between $125 Million to $140 Million
August 11, 2022
-
Kite Realty Group Trust Declares Quarterly Common Dividend of $0.22 per Common Share, a 5% Increase Over Previous Quarter and a 22% Year-over-Year Increase
August 10, 2022
-
PlantX’s Portfolio Coffee Establishes Partnership with Canadian Barista Academy
August 10, 2022
-
Lexaria Announces Positive Feedback from Pre-IND Meeting with FDA on DehydraTECH-CBD for Hypertension
August 10, 2022
-
The Alkaline Water Company Completes Company-Wide Review and Identifies Approximately $15 Million in Cost Savings and Margin Enhancements
August 9, 2022
-
Splash Beverage Group, Chairman and CEO, Robert Nistico Provides Corporate Update in Letter to Shareholders
August 9, 2022
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Developing Powerful Tech to Treat Hypertension
August 9, 2022
-
Nextech AR Launches Major Upgrade To Shopify app ARitize 3D
August 9, 2022
-
Bioasis Technologies Inc. Announces Stock Option Grants
August 8, 2022
-
PlantX Celebrates Grand Opening of XMarket Uptown in Chicago with Event Featuring Local Vegan Brands
August 8, 2022
-
LiveOne Announces Extension of East West Bank Credit Facility
August 4, 2022
-
Alkaline88® Adds Approximately 600 New Locations of Convenience Store Leader in Western States
August 3, 2022